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We present a novel method for deriving network models from molecular proﬁles of perturbed
cellular systems. The network models aim to predict quantitative outcomes of combinatorial
perturbations, such as drug pair treatments or multiple genetic alterations. Mathematically, we
represent the system by a set of nodes, representing molecular concentrations or cellular processes,
a perturbation vector and an interaction matrix. After perturbation, the system evolves in time
according to differential equations with built-in nonlinearity, similar to Hopﬁeld networks, capable
of representing epistasis and saturation effects. For a particular set of experiments, we derive the
interaction matrix by minimizing a composite error function, aiming at accuracy of prediction and
simplicity of network structure. To evaluate the predictive potential of the method, we performed 21
drug pair treatment experiments in a human breast cancer cell line (MCF7) with observation of
phospho-proteins and cell cycle markers. The best derived network model rediscovered known
interactions and contained interesting predictions. Possible applications include the discovery of
regulatory interactions, the design of targeted combination therapies and the engineering of
molecular biological networks.
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Introduction
Our ability to measure increasingly complete and accurate
molecular proﬁles of living cells motivates new quantitative
approaches to cell biology. For example, a key aim of systems
biology is to relate changes in molecular behavior to
phenotypic consequences. To achieve this aim, computational
models of cellular processes are extremely useful, if not
essential. Computational models can be used for the analysis
of experimental data, for the prediction of outcomes of unseen
experiments and for planning interventions designed to
modify system behavior. We have developed a particular
approach to constructing, optimizing and applying computa-
tional models of cellular processes, which we call Combina-
torial Perturbation-based Interaction Analysis (CoPIA). The
key ingredients of the approach are combinatorial inter-
vention, molecular observation at multiple points, model
construction in terms of nonlinear differential equations,
optimization of model parameters with simplicity constraints
and experimental validation.
The power of combinatorial perturbation
In molecular biology, a targeted perturbation typically inhibits
or activates function of biomolecules, e.g. as a result of drug
action, small RNA interference, genetic or epigenetic change
(Figure 1). In a single experiment, targeted perturbations
can be applied either singly or in combination. Combined
perturbation by several agents can be much more informative
than that by a single agent, as its effects typically reveal
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synergistic or antagonistic interactions. In addition, a large
number of independently informative experiments can be
performed if in each experiment a different small set of, e.g.
two or three, perturbants is chosen from a larger repertoire.
Thus, combinatorial perturbations are potentially powerful
investigational tools for extracting information about path-
waysofmolecularinteractionsincells(suchasAinactivatesB,
or X and Yare in the same pathway) (Avery and Wasserman,
1992; Kaufman et al, 2005; Kelleyand Ideker, 2005; Segre et al,
2005; Yeh et al, 2006; Leha ´r et al, 2007). Combinatorial
perturbations can also be powerful application tools when
Figure 1 Combinatorial perturbation and multiple input–multiple output (MIMO) models. Upper left: intuitive view of perturbations and their points of action. Small
inhibitory RNAs alter gene expression; natural protein ligands and small compounds act, e.g., on receptors, transporters or enzymes. Genetic alterations have diverse
functional effects. Perturbations can be natural or investigational. Observations (readouts) typically focus on a phenotype of interest, such as growth or differentiation,
and on observation points that are both practical and informative, such as transcripts, protein levels or covalent modiﬁcations, e.g. phosphorylation. Upper right: MIMO
model.Allkeysystemvariablesarerepresentedasrealnumbervariables,thecombinatorialperturbationsuiaswellastheirtargets,internalvariables,observationpoints
and phenotypic outputs yi. Inputs (upper layer, squares) affect the different dynamical variables of the system (circles), some of which can be observed (lower
layer, squares). The model represents a processing system that relates the input to the output through the interacting dynamical variables. Representation of coupled
perturbations (nonlinear effects) is a key requirement of the modeling method. When rate equations are linear (lower left), perturbation effects will combine additively.
However, in a well-parameterized system with nonlinear transfer functions (lower right), epistasis effects will arise, and downstream effects depend on pathway
organization. Below: uses of a derived MIMO model. When inputs and outputs are known, a model can be used to infer the internal mechanism of the system
(Interpretation). When the inputs and the system are known, the model can be used to predict a response (Prediction). When the system and the desired output are
known, the model can serve to design optimal modes of control (Control).
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combination of targeted drugs is considered a promising
strategy to improve treatment efﬁcacy, reduce off-targeteffects
and/or prevent evolution drug resistance (Borisy et al, 2003;
Keith et al, 2005; Komarova and Wodarz, 2005; Chou, 2006).
With recent advances in molecular technologies—e.g.,
targeted perturbation by small molecules, full-genome libraries
of small RNAs, highly speciﬁc antibody assays, massive
parallelization and imaging techniques—there is intense inter-
est in the investigational power of multiple perturbation
e x p e r i m e n t si nav a r i e t yo fb i o l o g i c a ls y s t e m s .T h ei n h e r e n t
complexity of such experiments raises signiﬁcant challenges in
data analysis and an acute need for improving modeling
approachescapableofcapturingeffectssuchastime-dependent
responses, feedback effects and nonlinear couplings.
Deriving system models from combinatorial
perturbation experiments
Computer simulation of pre-deﬁned pathways can be used to
predictepistasiseffectsandexplorehowpathwayorganization
shapes the perturbation response (Omholt et al, 2000; Segre
et al, 2005; Leha ´r et al, 2007). In many situations however,
observational data are provided but the pathway is unknown
or only partially known. To solve this problem, our com-
putational modeling approach enables users to construct a
complete differential equation model for a system from
combinatorial perturbation experiments. In the context of this
paper, the system of interest is deﬁned by a particular type of
cell, its environment, a time interval of observation and a
phenotypicchange,such ascelldeath orgrowth.The systemis
furthercharacterizedbyitspointsofintervention,suchasdrug
targets, and the points of observation, such as the phosphor-
ylation state of proteins involved in signaling processes
(Figure 1). To represent such a system mathematically, we
choose network models in which nodes represent molecular
concentrations or levels of activity and edges reﬂect the
inﬂuence of one node on the time derivative of another. The
time evolution of the system is modeled by linear differential
equations, modiﬁed by a nonlinear transfer function to reﬂect
properties of the system that are not explicitly modeled
(Figure 1). We present efﬁcient optimization algorithms to
ﬁnd models that achieve maximum agreement between
observation and prediction. Our algorithm is based on a
combination of a gradient descent method (to set dynamical
parameters) and a Monte Carlo process (to explore alternative
network connectivities). We make a software implementation
of CoPIA available as platform-independent software
(http://cbio.mskcc.org/copia).
Testing the predictive power of derived system
models
We perform combinatorial perturbation experiments in an
MCF7 breast cancer cell line to test the modeling framework in
the steady-state limit. In this test, we demonstrate how
observation of the effects of drug pair perturbations can be
exploited to deduce a network model of signaling and
phenotype control (reverse engineering of pathways). We
useobservedmolecularstateandgrowthphenotyperesponsesto
build predictive models and use these to explain the perturba-
tion–phenotype relationship in terms of coupling between
proteins in the EGFR/MAPK and PI3K/AKT pathways. Without
using known pathway biology, the resulting model reproduces
known regulatory couplings and negative feedback regulation
downstream of EGFR and PI3K/AKT/mTOR, and makes predic-
tions about possible roles of PKC-d and eIF4E in the control of
MAPK signaling and G1 arrest in MCF cells.
We conclude that CoPIA may be of interest as a broadly
applicable tool to construct models, discover regulatory
interactions and predict cellular responses. For instance,
researchers can measure a set of protein phosphorylation
responses to drug combinations and use the method to
automatically construct network models that predict the
response to novel drug combinations. Application of this
methodology to time-dependent experimental observations
would extend this predictive capability to the regimen of time-
dependent, rationally designed combinatorial therapy.
Results
Modeling the effects of combinatorial
perturbations
Multiple input–multiple output models
State space representation is commonly used in mathematical
modeling of input–output behavior in natural systems. In this
representation, the time behavior of the system state is
described by a ﬁrst-order differential equation
dy
dt
¼ fðyðtÞ;uðtÞÞ ð1Þ
where the vector y(t) represents state variables (the activities
of the system’s components), the vector u(t) represents
perturbations (external inﬂuences on the components) and f
is a linear or nonlinear transfer function (de Jong, 2002). For
example, y(t) can be the abundances of speciﬁc mRNAs or
proteins, whereas u(t) can be the concentrations of different
chemicalcompoundstowhichthecellsareexposed(Figure1).
In essence, state space models relate a system’s input to its
output. State space models with multiple inputs–outputs (that
is, y and u have more than one coordinate) are called multiple
input–multiple output (MIMO) models.
Linear MIMO models
When fis a linear function of yand u, the above model is called a
linear MIMO model. The mathematical properties of linear
MIMO models are well known (Ljung, 1986) and such models
have been applied to many biological problems, for example, the
construction of transcriptional network models (Tegner et al,
2003; Xiong et al, 2004; di Bernardo et al, 2005). Nevertheless,
linear models have a limitation in that they can only model
uncoupled perturbation effects (linear dose–response relation-
ships), whereas nonlinear effects (coupled perturbation effects)
are ignored (Figure 1; ‘Model representation’). As a result, linear
MIMO models are unable to capture important phenomena that
areknowntooccur incellularsystems, suchassaturationeffects,
switch-like effects and nonlinear interaction phenomena such as
genetic epistasis and pharmacological synergism.
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To overcome this limitation, we construct nonlinear
MIMO models capable of representing coupled perturbation
effects. Previously, other authors have observed that
complex gene knockout effects, including epistasis effects,
can be predicted in metabolic ﬂux networks where bounds
on the reaction rates are introduced (Fell and Small,
1986; Edwards and Palsson, 2000; Segre et al, 2005; Deutscher
et al, 2006). Similarly, metabolic systems with Michaelis–
Menten kinetics or transcriptional networks with bounds
on transcription rates will exhibit epistasis behavior
(Omholt et al, 2000; Leha ´r et al 2007). In the particular case
of the MIMO model, we expect more biologically realistic
behavior if one replaces the linear transfer function f with a
nonlinear transferfunction f that imposes bounds on the rates
of change of the system. Accordingly, we propose the class of
models
dyi
dt
¼ bifi
X
j
wijyjðtÞþuiðtÞ
!
  aiyiðtÞ; i ¼ 1;2;...;
 
ð2Þ
In this class of models, the matrix wij represents
the interactions between the molecules and processes
represented by the state variables of the system. (Intuitively,
the matrix elements wij can be thought of as a map of
the system, in which wij40 means ‘node j activates node i’,
whereas wijo0 corresponds to inhibition.) Furthermore,
ai40 represents the tendency of the system to return to
the initial state (yi¼0); bi40 are constants and fi is a
transfer function capable of capturing both switch-like
behavior and bounded reaction rates. Examples of such
functions include sigmoid functions, piece-wise linear
approximations of sigmoids or biochemically motivated
approximations such as the Hill or Michaelis–Menten
equations (Materials and methods).
Application of nonlinear MIMO models to combinatorial
perturbation experiments
We developed computer algorithms to infer nonlinear models
of the above type from experimental data, as speciﬁed by the
best-performing values of the coupling parameters wij and
other parameters. As detailed in Materials and methods,
the current implementation of our approach consists of the
followingsteps.First,thesystemofinterestissubjectedtoaset
of independent single or multiple target perturbation experi-
ments; and, for each perturbation vector (time-independent
instance of u), a readout vector (steady-state instance of y)i s
recorded. Second, we infer a nonlinear model that best
reproduces the experimental data (Materials and methods).
Speciﬁcally, we rely on parameter estimation techniques for
feedback systems to ﬁnd a model that minimizes a quadratic
error term between observed and predicted readouts, subject
to simplicity constraints on the number of interactions in the
system. Third, the ﬁtted model can be used to predict the
system’s response to unseen perturbations (for example,
combinations of drugs), and to gain new insight into the
system’s architecture.
Testing modeling power for combinatorial
perturbations in breast cancer cells
Dual drug perturbation experiments in MCF7 breast
cancer cells
To directly test the power of the approach, we performed an
independent experimental study in MCF7 human breast carci-
noma cells. As perturbants of the system, we chose compounds
targeting EGFR (ZD1839), mTOR (rapamycin), MEK
(PD0325901), PKC-d (rottlerin), PI3 kinase (LY294002) and
IGF1R (A12 anti-IGF1R inhibitory antibody). As relevant read-
outs of molecular and phenotypic responses, we chose phospho-
protein levels of seven regulators of survival, proliferation and
protein synthesis (p-AKT-S473, p-ERK-T202/Y204, p-MEK-S217/
S221, p-eIF4E-S209, p-c-RAF-S289/S296/S301, p-P70S6K-S371
and pS6-S235/S236) as well as ﬂow cytometric observation of
two phenotypic processes (cell cycle arrest and apoptosis)
(Figure 2). Inhibitors were administered singly and in pairs,
followed by EGF stimulation. When recording responses of
protein phosphorylation, we used the average response at 5 and
30min as the surrogate for steady-state values. To build models,
we represented the state of each of the above perturbation targets
(signaling proteins), as well as each of the readouts, by one state
variable yi. We then used the proposed optimization procedure
(Materials and methods) to estimate the coupling parameters wij
and other parameters, resulting in predictive models of response
in terms of these system variables.
Quantitative prediction of system response
We ﬁrst assessed the predictive power of the derived models
using leave-one-out cross-validation, in which one pair
perturbation is left out of the analysis and then its effect
predicted from information gained from all other perturba-
tions. The resulting predictions were reasonably accurate for
the nine different readouts. The best prediction was obtained
for p-S6 phospho-protein levels (cross-validation error
CV¼0.02, Pearson correlation r¼0.96) and the weakest for
the G1 arrest phenotype (CV¼0.07, r¼0.45) (Figure 2 and
Supplementary Table 1). We directly compared the perfor-
mance of our modeling approach to one using a corresponding
set of linear differential equations with the same optimization
procedure. By comparison, predictions using the nonlinear
approach agreed better with experimental observations for
eight of the nine readouts. Using the nonlinear modeling
approach, the prediction error was lower by up to 50% with
correspondingly better correlation between predictions and
experimental observations (Supplementary Table 1). Thus, we
conclude that our method is capable of deriving reasonably
accurate network models for the input–output behavior of
MCF7 cells with respect to the readouts used.
Detection of key regulatory mechanisms without
prior knowledge
From a set of perturbation experiments, how can one deduce
the logical network structure of activating and inhibiting
interactions between the key molecular components, similar
to the familiar pathway diagramsin publications summarizing
a set of molecular biological experiments? Here, we use the
derived network models with the smallest global error
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connectivity diagrams. The inference is based on the assump-
tion that interactions in sufﬁciently simple models that ﬁt
experimental observations, called ‘good’ models, represent an
underlying causal relationship between system components
modeled by the system variables yi. Such a relationship can be
either an indirect regulatory effect or a direct physical
interaction that would be observable in vitro with puriﬁed
components.UsingourMonteCarloalgorithm,wegenerateda
population of 450 good models from the MCF7 dual drug
perturbation experiments. From these, we assessed the
statistical signiﬁcance of the individual interactions both in
terms of a posterior probability (which is obtained directly
fromtheMonte Carlo process,see Materials and methods) and
a 90% conﬁdence interval constructed by boot-strapping
simulations (Table I). We now discuss the connectivity of the
best model, i.e. the one with the smallest error (schema in
Figure 3, explicit equations in Materials and methods) relative
to the known biology of regulatory pathways in the MCF7
breast cancer cell line.
Figure 2 Breast cancercells as amultiple input–multiple output system. To generate data for model construction, wetreated human MCF7 breast tumor cell lines with
one natural ligand (epidermal growth factor (EGF)) and six inhibitors, singly and in combination. The treatment protocol used EGF, an IGF1 receptor inhibitory antibody
(A12)andinhibitorsofthesignalingmoleculesEGFR,PI3K,mTOR,PKC-dandMEK.TheinhibitorsareZD1839,LY294002,rapamycin,rottlerinandPD0325901.Inthe
perturbation matrix (top panel, columns¼experiments, rows¼perturbations), a blue box indicates the presence of a particular perturbation and white indicates absence.
For each treatment, we used western blots to detect levels of the proteins phospho-AKT, phospho-ERK, phospho-MEK, phospho-eIF4E, phospho-c-RAF, phospho-
p70S6KandphosphopS6.WeusedaFACS-basedassaytoquantifyapoptosis(measuredasthe‘sub-G1fraction,’Materialsandmethods)andG1arrest(measuredas
theG1fraction). Here,representativeﬂowhistograms depicting cellcycledistributioninMCF7cultures treatedwithor withoutdrugare shown(oneexperiment isshown,
see Supplementary information for all measurements). Evaluation of predictive power: After model construction based on these experiments, we see good agreement
between experimental observation of the response of the MCF7 cell line to the 21 different perturbations (top, columns¼experiments, rows¼readouts) and the model
prediction (bottom). Statistical assessment is in Supplementary Table 1. For each readout, we quantify the system’s response by the phenotypic index deﬁned as log
relative response in treated versus untreated cells. For some drug combinations, the phenotypic readout increases as a result of perturbation (orange), for others it
decreases (blue).
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In comparing the inferred connectivity with mechanisms
known to occur in MCF7 cells (Table I), two caveats are
important. (1) The logical nodes in our models are deﬁned
precisely as the perturbed and observed molecular species,
i.e. the targets of drug perturbation and the targets of speciﬁc
observed antibody reactions, and may not be exactly identical
to a single molecular species. For example,‘EGFR’ refers to the
direct target(s) of activation by EGF and of inhibition by the
drug ZD1839, and these two are assumed to be identical. (2)
The models make no reference to unperturbed or unobserved
nodes, e.g. whereas p-AKT is in the network model, the
unphosphorylatedAKTisnot.Withthesecaveatsinmind,one
can use the models both for conﬁrmation and prediction of
interactions. Of the 23 interactions in the best model, 14 had
a posterior probability in the range of 20–99% (Table I). Of
these, several statistically robust interactions clearly conﬁrm
canonical pathway structures. (i) The MAPK cascade down-
streamoftheEGFreceptorisdetectedasachainofinteractions
between EGFR, MEK and ERK (Figure 3 and Table I). (ii) The
negative feedback regulation of MAPK signaling is captured as
negative interaction from ERK to EGFR, and as a moderately
signiﬁcant self-inhibition of MEK (see Discussion). (iii) PI3K-
dependent signaling and the tendency for MCF7 cells to be
dependent on AKT activation for survival are detected as
interactions between PI3K, AKTand the apoptosis phenotype.
(iv)Themodelinferencethatapoptosisiscontrolledbyp-AKT,
but not p-ERK, is in agreement with previous results in MCF7
cells (Simstein et al, 2003; DeFeo-Jones et al, 2005). (v) mTOR
downstream signaling is detected as interactions between
mTOR, p70S6K and ribosomal S6 protein (Mingo-Sion et al,
2005). The derivation of these expected interactions from a
small set of perturbation experiments, without prior pathway
Table I Statistical assessment of inferred interactions in MCF7 cells
Regulator Target Mean
interaction
90% CI Posterior probability (%) Comment
EGFR - MEK 0.78 (0.67, 0.88) 99 0 Activation of MEK by RTK signaling
MEK - p-ERK 0.39 (0.26, 0.48) 99 0 MAPK signaling
PI3K - p-AKT 0.57 (0.47, 0.69) 93 0 PI3K-dependent activation of AKT
PKC-d - p-RAF 0.25 (0.17, 0.32) 71 0 Prediction
mTOR - p-P70S6K 0.25 (0.20, 0.29) 41 0 mTOR signaling pathway
p-ERK - p-eIF4E 0.19 (0.14, 0.25) 38 0 Prediction
p-ERK - p-ERK 0.29 (0.22, 0.40) 35 0 Prediction
p-P70S6K - p-S6 0.54 (0.53, 0.56) 20 0 S6 kinase activates S6
Apoptosis - G1 arrest 0.37 (0.30, 0.44) 20 0 Prediction
G1 arrest - EGFR 0.39 (0.29, 0.49) 13 0 Low signiﬁcance prediction
MEK - p-RAF 0.29 (0.16, 0.41) 13 0 Low signiﬁcance prediction
p-eIF4E - PI3K 0.05 (0.02, 0.08) 13 1 Low signiﬁcance prediction
p-AKT
⊥
Apoptosis  0.39 ( 0.43,  0.36) 0 77 AKTcontrols survival in MCF7 cells
PKC-d
⊥
G1 arrest  0.12 ( 0.20,  0.06) 0 41 Prediction
p-ERK
⊥
EGFR  0.28 ( 0.42,  0.17) 0 36 MAPK negative feedback loop
G1 arrest
⊥
p-eIF4E  0.33 ( 0.36,  0.30) 0 32 Predicted bi-stable regulation
p-eIF4E
⊥
G1 arrest  0.19 ( 0.25,  0.12) 0 20 Predicted bi-stable regulation
Apoptosis
⊥
p-P70S6K  0.39 ( 0.42,  0.36) 0 19 Low signiﬁcance prediction
IGF1R
⊥
G1 arrest  0.06 ( 0.14,  0.01) 0 16 Low signiﬁcance prediction
G1 arrest
⊥
p-ERK  0.09 ( 0.16,  0.01) 1 15 Low signiﬁcance prediction
mTOR
⊥
Apoptosis  0.07 ( 0.12,  0.02) 1 12 Low signiﬁcance prediction
MEK
⊥
MEK  0.13 ( 0.21,  0.07) 0 8 Low signiﬁcance prediction
EGFR
⊥
p-RAF  0.03 ( 0.11,  0.04) 6 2 Low signiﬁcance prediction
Statistical assessment of inferred molecular interactions as shown in Figure 3. Column ‘Mean wij’ shows the average interaction strength between the target and the
regulator, as obtained from200 bootstrapping simulations (see Supplementary information). 90% conﬁdence intervals(CI) for the interaction strength areshown. The
left column of posterior probabilities shows the fraction of models with a positive regulation in the Monte Carlo simulation. The right column shows the fraction of
models with negative regulation (for instance, inhibition of apoptosis by p-AKTwas present in 77% of models). The names p-P70S6K and p-p70S6K are synonymous.
Figure3 UseofMIMOmodelstoinferregulatoryinteractionsinbreastcancercells.
The interaction matrix wij from a set of good models can be used to infer
regulatory interactions (squares¼inputs; circles¼internal system vari-
ables and other observables). Positive wij means activation and
negative wij means inhibition of the target. Interestingly, some of the
interactions are well known in MCF7 cells (green arcs) and others
constitute predictions (orange arcs). See Table I for functional
comments on interactions. No underlying pathway model was
used—the network is a straightforward interpretation of the optimized
model parameters wij.T h eE G F R -MEK-ERK and PI3K-AKT,
canonical pathways are identiﬁed. Also, note the detection of self-
inhibitory interactions in MEK/ERK signaling, identiﬁcation of eIF4E
and AKT as direct regulators of apoptosis and G1 arrest.
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building approach and provides some conﬁdence in the
concrete predictions of logical regulatory interactions for
MCF7 cells (Table I), which are discussed below.
Discussion
Insummary,ourevaluationin breastcancercellssupportstwo
main conclusions. First, our approach to model construction
can be used to build reasonably accurate quantitative
predictors of pathway responses to combinatorial drug
perturbation in MCF7 cells. Second, the quality of the deduced
interaction network suggests that well-parameterized non-
linear MIMO models are interpretable in terms of a network of
(direct and/or indirect) regulatory interactions. The inference
of network structure is surprisingly effective: the logical
network diagram in Figure 3 was derived de novo based on
only 21 experiments, using non-temporal data and only nine
experimental readouts and accurately reﬂects important
known regulatory interactions. This bodes well for future
applications inwhich the amount of readout data can easily be
an order of magnitude greater. In addition to yielding details of
intermolecular coupling, the method is sufﬁciently general to
allow predictive modeling of causal relationships between
biomolecular events and cellular phenotypic consequences,
such as growth or cell cycle arrest. The method lends itself to
multi-level modeling in the sense that molecular, mesoscopic
and macroscopic events can be modeled in a single framework
once appropriate state variables yi are deﬁned.
Software and technical aspects of implementation
Weaimto putthese toolsintothe handsof bothcomputational
and experimental biologists for widespread use and are
providing a software distribution of CoPIA in the supplement.
When applying the method in practice, three crucial technical
details are important. A user has to choose (i) which system
properties to represent by dynamical variables; (ii) a speciﬁc
form for the transfer function f; and (iii) protocol and
parameter values for the Monte Carlo simulation, or for a
similar exploration of solution space. The key parameters
include l, which enforces network sparsity to avoid over-
ﬁtting, and T, the temperature parameter, which ﬁne-tunes
the extent of non-optimal exploration of network space. In
Materials and methods, we provide guidelines for these
choices.
Complementarity to response surface models and
epistasis clustering
In a recent interesting work, Leha ´r et al (2007) used drug pairs
to perturb signaling pathways in cancer cells, and provided an
interpretation framework based on traditional pharmacologi-
cal models for two-drug response surfaces. Drug targets in the
PI3K and MAPK pathways were characterized by correlating
‘synergy proﬁles,’ demonstrating a link between network
connectivity and drug pair response. Such synergy proﬁles, in
turn, can be thought of as a generalization of the epistasis
matrix used by Segre et al (2005) as a basis for functional
clustering of genes. The approach proposed here is different in
the sense that it performs a global optimization that aims to
ﬁnd a fully parameterized model for the entire system. Such
models, in turn, can be used for additional purposes such as
making predictions of system responses, or making connec-
tivity information explicit as pathway diagrams. Preliminary
data suggest that CoPIA models can be used to interpret or
predict response surface data, as a function of drug concentra-
tions, as an alternative to the approach of Leha ´r et al, e.g. to
reduce experimental cost (S Nelander, unpublished data).
Finally, the differential equation CoPIA models can be easily
represented in standard systems biology formats, such as
BioModels (Le Nove `re et al, 2006) and be used with a number
of tools for model visualization, numerical simulation or
analytical characterization.
Relationship to neural models and Hopﬁeld
networks
The nonlinear representation proposed here, or related neural
models, has been used in biological contexts such as
transcriptional network modeling (Marnellos and Mjolsness,
1998; D’haeseleer et al, 2000; Omholt et al, 2000; Vohradsky,
2001; Li et al, 2004; Bonneau et al, 2006; Hart et al, 2006), in
synthetic biology (Kim et al, 2005, 2006) and for problems
such as approximation of inorganic chemical reactions
(Shenvi et al, 2004), but not for general cellular processes
and/or drug perturbations. In addition, CoPIA models are
similar, but not identical, to Hopﬁeld networks, a formalism
introduced to study computation in physical systems
(Hopﬁeld, 1982). To further motivate this class of models in
representingbiologicalsystems,weproposeanextendedeffort
to theoretically and empirically analyze how well biochemical
reactions can be approximated by neural functions, e.g.
reactions involved in DNA switches (Kim et al, 2005).
Conﬁrmed and predicted regulatory interactions in
MCF7 cells
In our analysis, we detected self-inhibitory feedback loops
downstream of the EGF receptor. This is compatible with the
observation that receptor activation of MAPK signaling
frequently leads to rapid feedback inhibition, for instance by
induced expression of inhibitory proteins (such as Sprouty
(Kim and Bar-Sagi, 2004) or MAPK phosphatases), or
inhibition of RAF by direct phosphorylation (Dougherty
et al, 2005). In our experiments, we are not able to identify
thefullcomplexityofthefeedbackloops,aswedidnotperturb
nodes such as ERKor RAF-1 or other proteins and used a short
EGF stimulation time. Additional predictions, such as (i) eIF4E
acting as a downstream effector of ERK, as well as (ii) PKC-d
counteracting the G1 arrest phenotype, are supported by
results in other cell types (Waskiewicz et al, 1997). Further-
more, the model predicts a mutually inhibitory interplay
between eIF4E activation by phosphorylation and G1 arrest,
consistent with the established role of eIF4E as a potent
oncogene and a master activator of a ‘regulon’ of cell cycle
activator genes (Culjkovic et al, 2006). However, the predicted
increase in p-RAF by PKC-d is paradoxical: the observed
phosphorylation sites on c-Raf (S289/S296/S301) are regarded
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PKC-d can activate MAPK signaling in a RAF-dependent way
(Jackson and Foster, 2004). Our prediction might suggest an
unknown direct effect mechanism, or an indirect effect that is
not captured in the present analysis. Finally, three less
interpretable and therefore interesting or potentially proble-
matic features of the network in Figure 3 are (i) the self-
activation of ERK; (ii) the activating arrow between
apoptosis and G1 arrest and, (iii) the fact that RAF is not
placed between EGFR and MEK, as in the usual representa-
tion of this pathway. Overall, a number of predictions can
be used to design experiments to validate or refute the model
predictions.
Future challenges
There are a number of future challenges and opportunities to
apply the method to important problems and to increase its
power. A key challenge is to use the method to extend known
pathways, by combining exploratory perturbation experi-
ments with the richness of biological knowledge in pathway
databases. This can be achieved by adding a priori known
nodes yj into the formalism and introducing a bias in the
network search that favors solutions compatible with prior
knowledge. To deal with off-target effects of perturbations and
incompletely known drug–target speciﬁcity, we propose a
variant algorithm in which drug–target couplings are para-
metersthataredeterminedbyoptimization.Suchavariantcan
be used in target identiﬁcation for interesting drugs, e.g.
compoundsthathaveadesirableeffectbutforwhichthetarget
is not yet known. To maximize the information value of
experiments, we propose to develop algorithms for the
design of experiments, e.g. based on the change of outcomes
with respect to particular parameters (King et al, 2004;
Vatcheva et al, 2006). We see tremendous opportunities in
new types of experiments. To generate more comprehensive
and more informative perturbations of a larger set of
cellular components, one can use combinatorial RNA inter-
ference (Friedman and Perrimon, 2006; Sahin et al, 2007). To
generatereadoutricherbyoneortwoordersofmagnitude,one
can use mass spectrometry of protein and phospho-protein
levels (Mann et al, 2002). The CoPIA method can be general-
ized to go beyond the steady-state approximation and
explicitly model the time behavior of system components by
minimizing the error function for a set of time series
experiments.
From models to therapies
The proposed combinatorial perturbation approach to cell
biology, CoPIA, presents a well-speciﬁed experimental–com-
putational procedure to construct predictive models for
perturbation responses in malignant cells. We suggest use of
such models to optimize therapeutic protocols, especially by
designing interventions using a combination of targeted
compounds administered in an optimal time sequence. Our
method constitutes a concrete step toward the active develop-
ment of network-oriented pharmacology.
Materials and methods
Computational methods
Phenotype prediction
The nonlinear MIMO model for combinatorial perturbation in cellular
systems is introduced in the Results section (equation (2)). When this
system is propagated through time, it will generally converge to a
stable, ﬁxed point (Pineda, 1987). We interpret this ﬁxed point as the
phenotypic response to the perturbation u. To calculate the ﬁxed point
given in a model, we used standard numerical integration methods
(ode15s (Mathworks Inc.) and DLSODE (Hindmarsh, 1993)). As the
class of models studied here can in principle have more than one
solution to the steady-state equation (Smits et al, 2006), we used the
convention—for practical purposes—to start each predictive simula-
tion from the unperturbed, wild-type steady state y¼0.
Overview of model ﬁtting algorithm
The procedure used to ﬁnd parameter values (for the ai’s, bi’s and
the wij’s) from experimental data is outlined below. As an overall
approach, we minimize a global error function that combines the
requirements of data ﬁt and simplicity. The error function is deﬁned as
Etotal ¼ ESSQ þ lESTRUCT ð3Þ
where ESSQ is the residual sum of squares error, which measures the
difference between the model’s predicted values and the correspond-
ing observational values for the subset of variables that are observed.
Theterm ESTRUCT is a penalty termthat measures the complexityof the
network and l is a tuning parameter that needs to be chosen; for l¼0
no emphasis is put on the model structure and increasingly sparse
(uncomplicated) models are obtained for increasing values of l.W e
used the l
0-norm of the regulatory matrix w to deﬁne ESTRUCTas
ESTRUCT ¼
X
i;j
jwi;jj
0 ð4Þ
where 0
0¼0. The l
0-norm is a common approach to enforce sparse
solutions in many machine-learning applications (Weston et al, 2002). In
principle,othernormscanbeused,suchasthel
1norm(Yeungetal,2002).
To minimize Etotal, we made combined use of a Monte Carlo
stochastic search algorithm (to search for the network structure) and
an efﬁcient gradient descent algorithm described by Pineda (1987) (to
set the parameters). In an outer loop of the algorithm, the Monte Carlo
process gradually updates the model structure (the set of non-zeros in
w). In an inner loop, we apply Pineda’s algorithm to ﬁt parameters
(ai’s, bi’s and non-zero wij’s). The output of the algorithm is a set of
complete ODE models, for example
dIGF1R
dt ¼ fð A12Þ IGF1R
dPI3K
dt ¼ 1:14fðþ0:05p-eIF4E   LY294002Þ 0:84PI3K
dmTOR
dt ¼ 1:04fð RapamycinÞ 0:96mTOR
dPKCdelta
dt ¼ 1:05fð RottlerinÞ 0:95PKCdelta
dMEK
dt ¼ 0:63fð 0:21MEK þ 0:76EGFR   PD901Þ 1:27MEK
dEGFR
dt ¼ 1:25fð 0:34p-ERK1=2 þ 0:37G1arrest   EGFÞ 0:66EGFR
dp-ERK1=2
dt ¼ 1:13fðþ0:41MEK þ 0:32p-ERK1=2   0:13G1arrestÞ 0:86p-ERK1=2
dp-AKT
dt ¼ fðþ0:55PI3KÞ-p-AKT
dp-P70S6K
dt ¼ 1:12fðþ0:28mTOR   0:41ApoptosisÞ 0:87p-P70S6K
dp-eIF4E
dt ¼ 1:07fðþ0:21p-ERK1=2   0:33G1arrestÞ 0:92p-eIF4E
dp-c-Raf
dt ¼ 1:08fðþ0:29PKCdelta þ 0:3MEK   0:07EGFRÞ 0:91p-c-Raf
dp-S6
dt ¼ 1:13fðþ0:52p-P70S6KÞ 0:85p-S6
dG1arrest
dt ¼ 1:11fð 0:05IGF1R   0:14PKCdelta
 0:24p-eIF4E þ 0:4ApoptosisÞ 0:87G1arrest
dApoptosis
dt ¼ 1:09fð 0:06mTOR   0:42p-AKTÞ 0:91Apoptosis
where fðxÞ¼tanhð2xÞ
8
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > :
ð5Þ
In the following two sections, we describe the gradient descent
algorithm and the Monte Carlo stochastic search algorithm more
thoroughly.
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descent algorithm
Assume a MIMO system with N dynamical variables y1,y2,y,yN,
of which a subset O of the variables can be observed experimentally.
A perturbation experiment is described by the pair (u, Y),
where u¼(u1,y,uN) is the perturbation treatment and Y¼{Yi|iAO}
is the experimental observation. As a mathematical model for
the relationship between the perturbation u and the experimentally
observed response Y, we use the dynamical system described in
the Results section (equation (2)). Let Y ˜ denote the steady state
of this dynamical system under the perturbation u. We then deﬁne
the sum of squares error for a single experiment as ESSQ ¼ P
i2O ðYi   ~ YiÞ
2.
We considera ﬁxed network structure, where some wij’s are ﬁxed to
zero. To describe the structure, we deﬁne a matrix U such that wij can
adopt a non-zero value if Uij¼1 and wij is zero if Uij¼0.
Given N,( u, Y) and U, we want to ﬁnd parameters ai’s, bi’s and the
non-zero wij’s that minimize the error ESSQ. For the special case where
l¼0,a¼1,b¼1,Pineda(1987)describedagradientdescentprocedure,
basedon solvingasetofdifferentialequationsinwhichtheweightswij
are updated following the gradient descent rule
dwij
dt
¼
 ZdESSQ
dwij
ð6Þ
Here, Z is a (small) number that sets the convergence speed, and t is a
‘pseudo-time’ that increases as the ﬁtting procedure progresses. We
use the update equations derived in D’haeseleer et al (2000) to extend
to an arbitrary a and b. The computation formula to minimize ESSQ
thus becomes:
dyi
dt ¼  aiyi þ bifið
PN
j¼1 wijyj þ uiÞð steady state YÞ
dzi
dt ¼  aizi þ bi
PN
j¼1 wjizjf
0
j
P
k wjkyj þ uj
     
þðYi   Y ˜iÞð error backpropagationÞ
dwij
dt ¼ Zf
0
i
PN
k¼1 wikyk þ ui
  
ziyj   Uijwij ðw updateÞ
dai
dt ¼  Zziyi ða updateÞ
dbi
dt ¼ Zzifi
PN
j¼1 wijyi
  
ðb updateÞ
8
> > > > > > > > > > > <
> > > > > > > > > > > :
ð7Þ
In these equations, z is an error propagation variable introduced for
computational purposes (Pineda, 1987). To ﬁt the model for a single
(u, Y) pair, we integrated these equations (DLSODE or ode15s) with
initial value 0 for w and 1 for a and b. The parameters were not
subjectedtoconstraintssuchas lowerandupperbounds. Solutions for
different stimulus–response pairs were combined using online
learning with momentum described in Duda et al (2000).
Outer loop: minimization of ETOTAL with an l-zero
penalty using stochastic search
We used a Markov Chain Monte Carlo approach (Ewens and
Grant, 2005) to minimize ETOTAL, and hence ﬁnd the optimal model
deﬁned by the network structure U and parameter values for a, b and
non-zero w’s.
In the algorithm, a set of models are maintained and a particular
model survives to the next iteration with probability proportional to
e Etotal=T (theBoltzmannfactor,whereTdenotesthetemperatureofthe
search). Hence, low-error models are more likely to be propagated to
next iteration.The temperature is typicallyhigh inthe beginningof the
search and low in the end.
The algorithm is outlined as follows:
1. Initialize with Ucurrent¼Ustart. Here, subindexes of U (Ucurrent, Ustart,
U1,U 2,y) refer to different realizations of the U matrix
(as opposed to U matrix elements. As Ustart, we use a N N matrix
of zeros.
2. Generate a set S¼{U ˜ 1,y,U ˜ k} of structures that are variations
of Ucurrent. For simplicity, we consider every structure that differs
from Ucurrent by one edge.
3. Estimate the parameters for each structure U ˜ 1,y,U ˜ k using the
variant of Pineda’s algorithm presented above. Record the
corresponding sum-of-square errors E1,y,Ek.
4. Calculate the total error for each topology as Ej
0¼Ejþl
P
Uj.
5. Use a decision rule R to select one of the alternate topologies,
Uselected.
6. Update the current topology, U ˜ current’U ˜ selected, potentially update
T, and repeat from step 2.
As decision rule R, we randomly select topology Uj with probability
Pj ¼
e E 0
j=T
P
i e E 0
i=T ð8Þ
Undercertain assumptions (the number of neighbors k is the same for
every topology U, neighbor is a mutual relationship, and all possible
topologies can be reached in a ﬁnite number of steps), the above
Markov chain will have a stationary probability distribution in which
the probability for a certain topology is proportional to its Boltzmann
factor Ewens and Grant (2005). For a sufﬁciently low temperature T,
the algorithm will converge to a probability optimum/error minimum.
Bootstrapping conﬁdence intervals
For a given model structure U, we used re-sampling of residuals to
generate boot-strapped conﬁdence intervals for the model parameters.
First, the model was ﬁtted using structure U and the original data, and
residuals were calculated as the best model ﬁt minus the original data.
Atotalof200‘new’datasetswasthenconstructedbyaddingrandomly
drawn residuals to each measurement (using residuals for the
corresponding experimental readout, i.e. p-MEK residuals were added
to p-MEK values and so on). For each such re-sampled data set, a
model was ﬁtted using the structure U. Subsequently, conﬁdence
intervalsforeachcouplingparameterwijwerecalculatedaspercentiles
5–95% across the 200 data sets.
Data preprocessing and parameter choices
The relationship between the model variable yi, a corresponding
experimental observation Yi and an experimental reference point Yref
or Ymax is deﬁned by a mapping function. In our evaluation in breast
cancer cells, we used the log relative change deﬁned as
yi ¼ log2 ðYi=YrefÞð 9Þ
The transfer functions fi should be chosen such that the interval
spanned by the experimental data corresponds to the target domain
of the function. We found it useful to standardize data to the interval
[ 1, þ1] and then to choose the sigmoid function accordingly. As the
reference (‘wild-type’) value Yref, we used the untreated controls. As
only one concentration level was used for every drug (chosen to be
around the ED90), we represented perturbation as ui¼1 if the drug was
added, and ui¼0 otherwise. We used fi¼tanh(yi) as the sigmoid
(suitable as it maps to the interval [ 1, þ1], another function with
this target domain, fi¼2/ptan
 1(cyi/2), gave very similar results).
Experimental methods
Cell culture and reagents
MCF7 cells were obtained from American Type Culture Collection;
maintained in 1:1 mixture of DME:F12 media supplemented with
100U/ml penicillin, 100g/ml streptomycin, 4mM glutamine and 10%
heat-inactivated fetal bovine serum and incubated at 371Ci n5 %C O 2.
The ﬁnal concentrations for inhibitors used for perturbation experi-
ments were 1mM ZD1839 (AstraZeneca), 10mM LY294002 (Calbio-
chem), 50nM PD0325901 (Pﬁzer), 2mM rottlerin (EMD), 10nM
rapamycin and 1.5mg/ml antibody A12 (ImClone Systems).
Immunoblotting
MCF7 cells were grown in 100mm dishes, and starved for 20h in PBS.
They were then treated with indicated concentrations of inhibitors
(details see Cell culture and reagents) or vehicle (DMSO) for 1h,
followed by adding EGF into the media (ﬁnal EGF concentration was
100ng/ml). After EGF stimulation for 5 or 30min in the presence of
drugs or DMSO, western blots were performed by harvesting MCF7
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Triton X-100, 150mM NaCl, 1.5mM MgCl2, 1mM EGTA, 1mM EDTA,
100mM NaF, 10mM sodium pyrophosphate, 1mM vanadate, 1 
protease cocktail II (Calbiochem) and 10% glycerol), separating 40mg
of each lysate by SDS–PAGE, transferring to PVDF membrane and
immunoblotting using speciﬁc primary and secondary antibodies and
chemoluminescence visualization on Kodak or HyBlotCL ﬁlms.
Antibodies for phospho-Akt-S473, phospho-ERK-T202/Y204, phos-
pho-MEK-S217/S221, phospho-eIF4E-S209, phospho-c-RAF-S289/
S296/S301, phospho-p70S6K-S371 and phospho-pS6-S235/S236 were
from Cell Signaling. Films were scanned by an microTEK scanner at
600 d.p.i. in gray scale. Bands were selected and quantiﬁed by
FUJIFILM Multi Gauge V3.0 software. Each membrane was normal-
ized to internal controls (with or without 100ng/ml EGF). The
membranes were stripped and reprobed with anti-beta actin (Sigma
no. A5441) to conﬁrm equal protein loading.
Flow cytometry analysis of cell cycle and apoptosis
MCF7 cells were seeded in six-well plates (200000 cells per well) and
grown for 20h in 10% FBS/DME:F12. Cells were then starved for 20h
in PBS, and then treated with indicated concentrations of inhibitors
(details see Cell culture and reagents) or DMSO for 1h, followed by
adding EGF into the media (ﬁnal EGF concentration was 100ng/ml).
After EGF stimulation for 24, 48 or 72h in the presence of drugs or
DMSO, cells were harvested by trypsinization, including both
suspended and adherent fractions, and washed in cold PBS. Cell
nuclei were prepared by the method described by Nusse et al and cell
cycle distribution was determined by ﬂow cytometric analysis of DNA
content (FACS) using red ﬂuorescence of 488nm excited ethidium
bromide-stained nuclei. The percentage of cells in the G1 phase (cell
cycle arrest) and sub-G1 fraction (apoptosis) was recorded.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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